Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FE944
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,821
Award facts
- Contract value 100% obligated
- $10,821.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $10,821.48 from the Defense Logistics Agency on January 14, 2026. This firm fixed-price order is scheduled for ultimate completion by January 15, 2026, and represents a non-set-aside competitive award. The delivery order falls under Amerisourcebergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 and extends through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
Amerisourcebergen Drug Corp operates as a subsidiary of Cencora, Inc., which does business as Amerisourcebergen and maintains the parent IDC with DLA valued at up to $999,999,999.00 through December 31, 2031. The Defense Logistics Agency procures pharmaceutical products and medical supplies through these vehicles to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The DLA's Medical Supply Chain utilizes these contracts to distribute a comprehensive portfolio of medical commodities, including specialty medications, brand-name and generic drugs, vaccines, and related healthcare supplies across multiple therapeutic domains in support of the Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DU26FE944?
SPE2DU26FE944 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DU26FE944 worth?
The government has obligated $10,821 on SPE2DU26FE944.
Is contract SPE2DU26FE944 an order under another contract?
Yes. SPE2DU26FE944 is a delivery order under SPE2DU25D5117, an indefinite delivery contract.
Was contract SPE2DU26FE944 competed?
The extent of competition for SPE2DU26FE944 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award